Literature DB >> 9446097

[Garré sclerosing osteomyelitis].

P Vienne1, G U Exner.   

Abstract

Osteomyelitis sclerosans Garré is still not completely understood. In spite of the fact that it is caused by bacterial infection, in most cases no bacterial growth can be discovered in culture. Furthermore, it remains open whether the chronic process is maintained by low-grade persistent infection or is maintained by itself after sterilization of the infection. Newer studies that may prove the presence of bacteria, e.g., by PCR, may elucidate the causes in the future. Sclerosing bone disease, sometimes multifocal, which present the same clinical, radiographic and histological features as chronic sclerosing osteomyelitis may be associated with diseases such as palmoplantar pustulosis, colitis ulcerosa, Crohn's disease, etc. and are reported as SAPHO (synovitis acne pustulosis hyperostosis osteitis) syndrome. In these diseases bacterial growth is almost always negative. However, temporary improvement under antibiotic therapy may be observed. A relationship between typical isolated chronic sclerosing osteomyelitis and SAPHO syndrome may exist, but the diseases should at present be differentiated. Neoplasms such as osteoid osteoma, Ewing sarcoma, or eosinophilic granuloma may simulate primary sclerosing osteomyelitis, and pathological examination of peripherally taken specimens may appear to be compatible with the diagnosis of sclerosing osteomyelitis. It should be appreciated that malignant tumors--even though this is the exception--can present a chronic, mild picture. Treatment of osteomyelitis sclerosans Garré needs be determined on an individual basis. A conservative approach with antibiotics usually leads only to temporary pain relief. The biopsy with opening of the medullary canal is sometimes sufficient for healing, while in extreme situations only segmental or even complete resection of the diseased bone case result in a permanent cure.

Entities:  

Mesh:

Year:  1997        PMID: 9446097

Source DB:  PubMed          Journal:  Orthopade        ISSN: 0085-4530            Impact factor:   1.087


  4 in total

1.  Sclerosing osteomyelitis of Garré: management of femoral pain by intramedullary nailing.

Authors:  Nicola Bader Vannet; Huw L M Williams; Brendan Healy; Rhidian Morgan-Jones
Journal:  BMJ Case Rep       Date:  2014-12-23

Review 2.  [Expert opinion problems in the evaluation of osteomyelitis].

Authors:  C Neugebauer; R Graf
Journal:  Orthopade       Date:  2004-05       Impact factor: 1.087

Review 3.  [Pediatric osteomyelitis].

Authors:  A Jansson; V Jansson; A von Liebe
Journal:  Orthopade       Date:  2009-03       Impact factor: 1.087

4.  Garré's sclerosing osteomyelitis: case report.

Authors:  Frederico Barra de Moraes; Tainá Melo Vieira Motta; Alessandra Assis Severin; Deniel de Alencar Faria; Fernanda de Oliveira César; Siderlei de Souza Carneiro
Journal:  Rev Bras Ortop       Date:  2014-04-24
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.